AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Biotec Pharmacon has all results from Phase III trials with beta glucan.

Chemical Business Newsbase

| November 03, 2009 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

All data procedures have been completed for both Biotec Pharmacon's Phase III studies with soluble beta 1,3/1,6 glucan for the treatment of diabetic …

Related articles from newspapers, magazines, journals, and more
Biotec Pharmacon ASA (NO) - Completed patient inclusion in the first Phase...
News wire article from: Chemical Business Newsbase March 16, 2009 700+ words
Biotec Pharmacon completes patient recruitment for Phase III study with SBG.
News wire article from: Chemical Business Newsbase March 16, 2009 700+ words
Favourable ruling for Biotec Pharmacon in U.S patent case.
News wire article from: Europe Intelligence Wire January 30, 2009 700+ words
Biotec Pharmacon share price down 80%.
News wire article from: Chemical Business Newsbase November 23, 2009 700+ words
Progress in Biotec Pharmacon research projects.
News wire article from: Chemical Business Newsbase January 13, 2009 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily